Grifols Approves IPO for US Biopharma Business

Grifols, a global healthcare company, has approved an initial public offering (IPO) for a segment of its biopharma business located in the United States, following earlier considerations.

24 Mar, 21:11 — 24 Mar, 21:11

Post Share

Sources

Showing 1 of 3 sources

ReutersVery High2h ago

Grifols approves IPO of its US biopharma business - Reuters

Grifols approves IPO of its US biopharma business Reuters

Read full article →

Coverage Timeline

First report: Reuters · 24 Mar, 21:11|Full coverage: 3 · 1h|Window: 1h

Left-leaningCenterRight-leaning

Reuters24 Mar, 21:11First to report

Grifols approves IPO of its US biopharma business - Reuters

seeking-alpha24 Mar, 21:40

Grifols considers IPO of part of its US biopharma business

el-mundo24 Mar, 22:24Latest update

PERSPECTA

PERSPECTA

Grifols Approves IPO for US Biopharma Business

Sources

Grifols approves IPO of its US biopharma business - Reuters

Coverage Timeline

Grifols approves IPO of its US biopharma business - Reuters

Grifols considers IPO of part of its US biopharma business

Grifols prepara la salida a bolsa de su negocio de Biopharma en Estados Unidos

Related Stories

Philippine President Marcos Declares Energy Emergency, Rolls Out Subsidies, and Eyes Joint Gas Development Amid Oil Crisis

President oversees rollout of fuel subsidies

Gov’t allots P20B to buy 2 million barrels of diesel

Philippine Government Reduces Airport and Ro-ro Terminal Fees

PERSPECTA